Found 8 matching trials
Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP) PHASE3 This a double-blind, randomized, placebo-controlled clinical trial to deter...
Show More Location
Lafayette General Medical Center
Learn More & Join Trial
PROLIFIC ChemoprophylaxisTrial (COVID-19) PHASE3 The number of confirmed cases of COVID-19 infectious disease arising from t...
Show More Location
Cambridge University Hospitals NHS Foundation Trust
Learn More & Join Trial
Will Hydroxychloroquine Impede or Prevent COVID-19 PHASE3 This is a prospective, multi-site study designed to evaluate whether the us...
Show More Location
Henry Ford Hospital
Learn More & Join Trial
SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY) N/A The goal of this observational study is to comprehensively profile six immu...
Show More Location
Radboud University Medical Center
Learn More & Join Trial
Preventing COVID-19 in Healthcare Workers With HCQ: A RCT PHASE2 Healthcare workers (HCW) at risk of Covid-19 will have baseline serology fo...
Show More Location
Multiple Locations
Learn More & Join Trial
Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory PHASE2 This is a Phase II, open label, single-arm trial study of adding hydroxychl...
Show More Location
Northwestern University
Learn More & Join Trial
Gedatolisib, Hydroxychloroquine or the Combination for Prevention of Recurrent Breast Cancer ("GLACIER") PHASE1 This clinical trial will assess the safety and early efficacy of the role o...
Show More Location
Abramson Cancer Center of the University of Pennsylvania
Learn More & Join Trial
MEK and Autophagy Inhibition in Metastatic/Locally Advanced, Unresectable Neuroblastoma RAS (NRAS) Melanoma NA Patients with metastatic Neuroblastoma RAS (NRAS) melanoma are currently tr...
Show More Learn More & Join Trial